Welcome to Dividends Inside
Welcome to Dividends Inside!

The platform is currently in beta, so some features and data may still change as we improve the service. If you have questions, feedback, or run into anything unexpected, please contact us at info@dividendsinside.com.

Horizon Space Acquisition Corporation II

HSPTR
$0.22 (- $0.08 - 25.67%)
Last updated: 2026-05-20 20:41 UTC
HSPTR Metrics
Exchange
🇺🇸 NASDAQ XNMS
Nasdaq/NMS (Global Market)United StatesAmerica/New_York
Sector N/A
Industry N/A
ISINN/A
Market Price0.22
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend Frequency N/A
P/E RatioN/A
EPSN/A
Market CapN/A
Book Value-0.05
Price to Book-4.583
Beta1.0
52w High0.22
52w Low0.22
Next Earnings DateN/A
About the Company
Horizon Space Acquisition Corporation II is a blank check company, also known as a special purpose acquisition company (SPAC), created for the purpose of effecting a merger, share exchange, asset acquisition, or similar business combination with one or more businesses. SPACs like Horizon Space Acquisition Corporation II provide a streamlined method for private companies, particularly those in sectors such as technology, healthcare, or energy, to access public capital markets without undergoing the traditional initial public offering (IPO) process. This asset stands out due to its potential to invest in industries poised for significant growth and innovation. The strategic advantage of SPACs lies in their ability to mobilize rapidly and inject flexible capital into high-potential projects. Horizon Space Acquisition Corporation II lends investors exposure to future-forward markets, encapsulating entrepreneurial ventures in nascent stages. Its presence underscores the evolving dynamics of how public offerings and capital raises are structured, reflecting an innovative shift in financial architectures aimed at optimizing market opportunities and investor engagement.
Price History
Latest News for HSPTR
Horizon Space Acquisition II Corp. Clarifies Redemption Process for Business Combination Shareholder Meeting and Extension Shareholder Meeting
New York, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Horizon Space Acquisition II Corp. (the “Company” or “HSPT”) (NASDAQ: HSPT) today clarified the redemption process for (i) the extraordinary general meeting for its proposed business combination (the “Business Combination”) with SL BIO Ltd. (“SL Bio”), which will be held on February 12, 2026 (the “Business Combination Meeting”), and (ii) the extraordinary general meeting for its proposed amendments to HSPT’s current amended and restated memorandum
Horizon Space Acquisition II postpones extraordinary general meeting
Horizon Space Acquisition II (HSPT) announced that it postponed the extraordinary general meeting originally scheduled on February 3, 2026 to February 12, 2026 to allow the Company “additional time to engage with its shareholders,” the company said. Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential Published first on TheFly – the
Horizon Space Acquisition II Corp. Postponed the Extraordinary General Meeting to February 12, 2026 and Extended the Redemption Request Deadline
New York, NY, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Horizon Space Acquisition II Corp. (the “Company” or “HSPT”) (NASDAQ: HSPT) today announced that it postponed the extraordinary general meeting (the “Extraordinary Meeting”) originally scheduled at 9:00 a.m. Eastern Time, on February 3, 2026, to 9:00 a.m. Eastern Time, on February 12, 2026 (the “Postponement”) to allow the Company additional time to engage with its shareholders. There is no change to the location, the record date, the purpose or an
SL BIO Ltd. and Horizon Space Acquisition II Corp. Announce Registration Statement Effectiveness and Extraordinary General Meeting Date to Approve Business Combination
TAIPEI, Taiwan & NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. ("SL Bio" or the “Company”), a biomedical company specializing in developing innovative cellular and gene therapies, and Horizon Space Acquisition II Corp. (Nasdaq: HSPT) ("HSPT"), a publicly traded special purpose acquisition company , today announced that the registration statement on Form F-4 (the “Registration Statement”), in connection with HSPT’s previously announced proposed business combination (the “Business Combin
Horizon Space Acquisition II Corp. Announces Definitive Business Combination Agreement with SL Bio Ltd.
NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Horizon Space Acquisition II Corp. ("HSPT") (Nasdaq:HSPT), a publicly traded special purpose acquisition company, and SL Bio Ltd. ("SL Bio"), a clinical-stage biomedical company specialized in developing ...